Mixed medullary-follicular-derived carcinomas of the thyroid gland

Advances in Anatomic Pathology

Volumn 17, Issue 4, 2010, Pages 282-285

  Sadow, Peter M ^a   Hunt, Jennifer L ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

c cell tumors; collission tumor; follicular carcinoma; medullary thyroid carcinoma; mixed tumor; papillary carcinoma

Indexed keywords

B RAF KINASE; PROTEIN RET;

CANCER MORPHOLOGY; CLINICAL FEATURE; GENE MUTATION; HISTOPATHOLOGY; HUMAN; MEDULLARY CARCINOMA; METASTASIS; MIXED MEDULLARY FOLLICULAR THYROID CARCINOMA; MIXED TUMOR; MOLECULAR GENETICS; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; THYROID FOLLICULAR CARCINOMA; TUMOR LOCALIZATION;

CARCINOMA, MEDULLARY; CARCINOMA, PAPILLARY, FOLLICULAR; HUMANS; THYROID NEOPLASMS;

EID: 77954511775     PISSN: 10724109     EISSN: 15334031     Source Type: Journal    
DOI: 10.1097/PAP.0b013e3181e4ab3e     Document Type: Review

References (34)

1. De Felice M, Di Lauro R. Thyroid development and its disorders: genetics and molecular mechanisms. Endocr Rev. 2004;25:722-746. (Pubitemid 39362295)
2. Brown EM, Hebert SC. The first annual bayard D. Catherwood memorial lecture. Ca2+-receptor-mediated regulation of parathyroid and renal function. Am J Med Sci. 1996;312:99-109.
3. Gimm O, Sutter T, Dralle H. Diagnosis and therapy of sporadic and familial medullary thyroid carcinoma. J Cancer Res Clin Oncol. 2001;127:156-165. (Pubitemid 32449066)
4. Naot D, Cornish J. The role of peptides and receptors of the calcitonin family in the regulation of bone metabolism. Bone. 2008;43:813-818.
5. Gharib H, McConahey WM, Tiegs RD, et al. Medullary thyroid carcinoma: clinicopathologic features and long-term follow-up of 65 patients treated during 1946 through 1970. Mayo Clinic Proceedings. 1992;67:934-940.
6. Hyer SL, Vini L, A'Hern R, Harmer C. Medullary thyroid cancer: multivariate analysis of prognostic factors influencing survival. Eur J Surg Oncol. 2000;26:686-690.
7. Saad MF, Ordonez NG, Rashid RK, et al. Medullary carcinoma of the thyroid. A study of the clinical features and prognostic factors in 161 patients. Medicine. 1984;63:319-342.
8. Hundahl SA, Cady B, Cunningham MP, et al. Initial results from a prospective cohort study of 5583 cases of thyroid carcinoma treated in the united states during 1996. US and German Thyroid Cancer Study Group. An American College of Surgeons Commission on Cancer Patient Care Evaluation study. Cancer. 2000;89:202-217. (Pubitemid 30451292)
9. Modigliani E, Cohen R, Campos JM, et al. Prognostic factors for survival and for biochemical cure in medullary thyroid carcinoma: results in 899 patients. The GETC Study Group. Groupe d'etude des tumeurs a calcitonine. Clin Endocrinol. 1998;48:265-273.
10. Franc S, Niccoli-Sire P, Cohen R, et al. Complete surgical lymph node resection does not prevent authentic recurrences of medullary thyroid carcinoma. Clin Endocrinol. 2001;55:403-409. (Pubitemid 32823051)
11. Fuchshuber PR, Loree TR, Hicks WL Jr, et al. Medullary carcinoma of the thyroid: prognostic factors and treatment recommendations. Annals of Surgical Oncology. 1998;5:81-86. (Pubitemid 28328062)
12. Saller B, Feldmann G, Haupt K, et al. RT-PCR-based detection of circulating calcitonin-producing cells in patients with advanced medullary thyroid cancer. J Clin Endocrinol Metabolism. 2002;87:292-296. (Pubitemid 34084704)
13. Mulligan LM, Gardner E, Smith BA, et al. Genetic events in tumour initiation and progression in multiple endocrine neoplasia type 2. Gene Chromosome Canc. 1993;6:166-177. (Pubitemid 23079559)
14. Elisei R, Cosci B, Romei C, et al. Prognostic significance of somatic RET oncogene mutations in sporadic medullary thyroid cancer: a 10-year follow-up study. J Clin Endocrinol Metab. 2008;93:682-687. (Pubitemid 351398539)
15. Bhattacharyya N. A population-based analysis of survival factors in differentiated and medullary thyroid carcinoma. Otolaryngol Head Neck Surg. 2003;128:115-123. (Pubitemid 36246129)
16. Nguyen TD, Chassard JL, Lagarde P, et al. Results of postoperative radiation therapy in medullary carcinoma of the thyroid: a retrospective study by the French Federation of Cancer Institutes-the Radiotherapy Cooperative Group. Radiother Oncol. 1992;23:1-5.
17. De Besi P, Busnardo B, Toso S, et al. Combined chemotherapy with bleomycin, adriamycin, and platinum in advanced thyroid cancer. J Endocrinol Invest. 1991;14:475-480.
18. Heshmati HM, Gharib H, van Heerden JA, et al. Advances and controversies in the diagnosis and management of medullary thyroid carcinoma. Am J Med. 1997;103:60-69. (Pubitemid 27314189)
19. Vantyghem MC, Pigny P, Leteurtre E, et al. Thyroid carcinomas involving follicular and parafollicular C cells: seventeen cases with characterization of RET oncogenic activation. Thyroid. 2004;14:842-847. (Pubitemid 39489009)
20. Nangue C, Bron L, Portmann L, et al. Mixed medullary-papillary carcinoma of the thyroid: report of a case and review of the literature. Head Neck. 2009;31:968-974.
21. Dionigi G, Castano P, Bertolini V, et al. Simultaneous medullary and papillary thyroid cancer: two case reports. J Med Case Reports. 2007;1:133. (Pubitemid 351837226)
22. Shiroko T, Yokoo N, Okamoto K, et al. Mixed medullary-papillary carcinoma of the thyroid with lymph node meta-stases: report of a case. Surg Today. 2001;31:317-321. (Pubitemid 32260941)
23. Papotti M, Volante M, Komminoth P, et al. Thyroid carcinomas with mixed follicular and C-cell differentiation patterns. Semin Diagn Pathol. 2000;17:109-119. (Pubitemid 30322272)
24. Volante M, Papotti M, Roth J, et al. Mixed medullary-follicular thyroid carcinoma. Molecular evidence for a dual origin of tumor components. Am J Pathol. 1999;155: 1499-1509.
25. Papotti M, Negro F, Carney JA, et al. Mixed medullary-follicular carcinoma of the thyroid. A morphological, immunohistochemical and in situ hybridization analysis of 11 cases. Virchows Arch. 1997;430:397-405. (Pubitemid 27202106)
26. Macak J, Vaverkova H, Dushova M, et al. Medullary and mixed medullary-papillary carcinoma of the thyroid gland. Pathologica. 1997;89:317-322. (Pubitemid 127777509)
27. Mizukami Y, Nonomura A, Michigishi T, et al. Mixed medullary-follicular carcinoma of the thyroid gland: a clinico-pathologic variant of medullary thyroid carcinoma. Mod Pathol. 1996;9:631-635. (Pubitemid 26227563)
28. Matias-Guiu X, Caixas A, Costa I, et al. Compound medullary-papillary carcinoma of the thyroid: true mixed versus collision tumour (corrected). Histopathology. 1994;25: 183-185.
29. Lax SF, Beham A, Kronberger-Schonecker D, et al. Coexistence of papillary and medullary carcinoma of the thyroid gland-mixed or collision tumour? Clinicopathological analysis of three cases. Virchows Arch. 1994;424:441-447. (Pubitemid 24185399)
30. Apel RL, Alpert LC, Rizzo A, et al. A metastasizing composite carcinoma of the thyroid with distinct medullary and papillary components. Arch Pathol Lab Med. 1994;118: 1143-1147. (Pubitemid 24345843)
31. Michal M, Curik R, Macak J, et al. Mixed medullary-follicular and medullary-papillary carcinoma of the thyroid: one or two entities? Zentralbl Pathol. 1993;139:333-335.
32. Albores-Saavedra J, Gorraez de la Mora T, de la Torre-Rendon F, et al. Mixed medullary-papillary carcinoma of the thyroid: a previously unrecognized variant of thyroid carcinoma. Hum Pathol. 1990;21:1151-1155. (Pubitemid 20381998)
33. Parker LN, Kollin J, Wu SY, et al. Carcinoma of the thyroid with a mixed medullary, papillary, follicular, and undiffer-entiated pattern. Arch Intern Med. 1985;145:1507-1509. (Pubitemid 15049810)
34. Rossi S, Fugazzola L, De Pasquale L, et al. Medullary and papillary carcinoma of the thyroid gland occurring as a collision tumour: report of three cases with molecular analysis and review of the literature. Endocr Relat Cancer. 2005;12: 281-289. (Pubitemid 40896447)